The effect of diabetes mellitus on opiate-mediated inhibition of calcium current density (I DCa [ 
Introduction
Diabetic neuropathy is the most common form of peripheral neuropathy in the Western world, with metabolic, functional, and morphological changes in peripheral nerves documented in both human and animal models of diabetes mellitus (1) (2) (3) (4) (5) . Many of the abnormalities described in peripheral nerves of animal and human diabetics, such as decreased conduction velocity, axonal swelling, axo-glial dysjunction, and nerve fiber loss (1, 6) have been linked to metabolic alterations such as decreased myo-inositol tissue levels, decreased Na ϩ ,K ϩ -ATPase activity, mitochondrial dysfunction, and altered calcium signaling (7) (8) (9) .
Considerable evidence suggests that metabolic over-stimulation by cytosolic calcium ([Ca 1 may contribute to neuronal cell injury (10) . Diabetes has been correlated with impaired calcium signaling in many tissues from diabetic animals (8) . An important contribution to [Ca 2 ϩ ] i in neurons is made by the entry of external Ca 2 ϩ through voltage-dependent calcium channels (11) . We recently reported enhancement of multiple, voltage-dependent whole-cell calcium currents (I Ca ) in acutely dissociated, capsaicin-sensitive dorsal root ganglion (DRG) neurons from the spontaneously diabetic BioBreeding/ Worcester (BB/W)-rat model of type I human diabetes mellitus (9) . The magnitude of the current enhancement increased with the duration of diabetes and nerve conduction velocity slowed. Both abnormalities were prevented by long-term oral treatment of diabetic animals with an aldose reductase inhibitor.
Endogenous opiates, such as dynorphin A (Dyn A), have been detected in dorsal root ganglia from adult rats (12) , and local release of opiate transmitters may play an important role in modulating neurotransmission in primary afferent pathways. Decreased sensitivity to opiates at the spinal level, as evidenced by decreased inhibition of tail flick response to noxious stimuli (13) and impaired vagal transport of opiate receptors (14) have been previously demonstrated in diabetic animal models. However, the cellular mechanism(s) underlying the decreased neuronal response to opiates in diabetes are unknown. Because previous studies suggested that calcium channels were affected in diabetes mellitus (9), we hypothesized that altered opiate-mediated regulation of neuronal calcium channels might contribute to the changes in calcium signaling observed in diabetes. Activation of and opiate receptors on DRG neurons inhibits calcium influx through voltage-activated calcium channels via a pertussis-sensitive, inhibitory (G i/o ) G protein-coupled pathway (15) (16) (17) . We compared the inhibitory effect of the opiate agonist Dyn A on whole-cell, voltage-dependent calcium current density (I DCa ) and [Ca ] i was monitored using the Fura-2 method, to determine whether the increase in I DCa observed in diabetes was associated with parallel alterations in [Ca 2 ϩ ] i . These studies have been presented in preliminary form (18) .
Methods
Animal model. Prior approval for these experiments was obtained from the University of Michigan Committee on Use and Care of Ani-mals (Authorization No. 3593A [2] ), according to National Institutes of Health (NIH) guidelines. Two groups of male BB/W-rats were used: ( a ) adult, nondiabetic controls aged 9-13 mo and ( b ) agematched diabetic rats treated with daily insulin injection (diabetic duration 7-10 mo). Prediabetic and non-diabetes-prone animals were obtained from the NIH-sponsored colony at the University of Massachusetts (Worcester, MA) and maintained at the Michigan Diabetes Research and Training Center. After the onset of diabetes (as determined by glucosuria during daily urine glucose monitoring), ultralente insulin (0.4-3.0 IU d Ϫ 1 ; Novo Nordisk, Princeton, NJ) was administered subcutaneously daily to maintain hyperglycemic blood glucose levels between 16 and 25 mM liter Ϫ 1 (300-450 mg dl
) and prevent ketoacidosis. Body weight, urinary glucose, and ketone bodies were monitored daily, and the insulin dose titrated as described previously (19) . Blood glucose levels were monitored daily until the desired plasma glucose levels were achieved, and biweekly thereafter. Shortly after onset of diabetes, a subset of six diabetic animals had recording electrodes implanted on the left sciatic nerve for measurement of nerve conduction velocity (5) . An equal number of nondiabetic, age-matched control animals were similarly prepared. Nerve conduction velocity was measured within 2 wk of killing.
Cell dissociation. Isolated, acutely dissociated DRG neurons were aseptically prepared from animals diabetic for 7-10 mo or agematched control animals using techniques described previously (9) . Thoracic DRGs were extracted from the spinal column, trimmed, minced, and incubated with 0.3% collagenase type II (Sigma Chemical Co., St. Louis, MO) and 0.1% bovine trypsin type I (Sigma) prepared in sterile MEM (GIBCO BRL, Grand Island, NY) supplemented with 16 mM NaHCO 3 and 28 mM d -glucose (320 mosmol kg Ϫ 1 ). After enzyme treatment, the minced DRGs were triturated and centrifuged to produce isolated neurons. After resuspension in supplemented MEM containing 10% horse serum (GIBCO), neurons were plated onto poly-l -lysine-coated glass coverslips. Nerve growth factor was not added to the culture medium. Coverslips were incubated in 93% air ϩ 7% CO 2 at 37 Њ C for 1.5-7 h before experiments were performed.
Drug preparation. Omega-conotoxin GVIA ( -CgTx) 1 mM stock solution (Sigma Chemical Co.) was prepared with filtered distilled water, lyophilized in 10 l aliquots, and stored at Ϫ 20 Њ C. On the recording day, 10 M -CgTx was prepared by diluting the lyophilized stock with external recording solution. Capsaicin stock solution (10 mM; Sigma) in 95% ethanol was stored at 4 Њ C. On the experimental day, concentrations of 0.1 and 1 M capsaicin were prepared by diluting the stock solution with electrophysiologic external recording solution and Fura-2 recording medium, respectively. Dyn A (Peninsula Laboratories, Inc., Belmont, CA) was diluted to 10 mM with distilled water containing 0.1% acetic acid, lyophilized, and stored at Ϫ 20 Њ C. On the recording day, working solutions of Dyn A (1, 3, and 5 M) were made by dilution either with external recording solution containing 0.1% BSA (Sigma) for application during electrophysiologic recording, or Fura-2 recording medium for application during measurement of [Ca 2 ϩ ] i . The above working solutions were kept on ice until used. In experiments testing the effects of pertussis toxin (PTX; Sigma), culture dishes were preincubated with medium containing 250 ng ml Ϫ 1 PTX for 3-4 h before recording. Whole-cell voltage-clamp recordings. Phase-bright DRGs, 20-40 mm in diameter, were selected using a micrometer in the microscope objective. Voltage-clamp recordings using the whole-cell variant of the patch clamp technique (20) were performed at room temperature with glass recording patch pipettes (Fisher Microhematocrit tubes; Fisher Scientific Co., Pittsburgh, PA). Electrode resistances were 1-2 M ⍀ , and seal resistances Ͼ 1 G ⍀ . Experiments were performed in a nonperfused culture dish containing the following external bath solution: (mM) 5 CaCl 2 , 67 choline Cl, 100 tetraethylammonium chloride, 5.6 glucose, 5. ) was adjusted to 10-15% below that of the external recording solution using distilled water. High-threshold calcium currents were elicited by depolarizing voltage steps generated using the program CLAMPEX (pCLAMP; Axon Instruments, Foster City, CA). Currents were recorded using an Axopatch 1D patch clamp amplifier (Axon Instruments) with an input resistance of 1-3 M ⍀ , filtered with a Bessel filter at 10 kHz ( Ϫ 3 decibels), sampled at 20 kHz, and stored on hard disk as binary data files. Neurons were clamped at a holding potential (V h ) ϭ Ϫ 80 mV. Immediately after patch rupture, 10 depolarizing calibration voltage steps ( ϩ 5 mV; 12 ms duration) were applied at 1 s intervals. High-threshold currents were evoked at 30 s intervals by 100 ms duration depolarizations to ϩ 10 mV. The total duration of recording was ‫ف‬ 20 min from the time of patch rupture. Currents elicited by the depolarization protocol described above increased in amplitude by 20-30% for the first 3-5 min ("runup"), then steadily decreased to ‫ف‬ 60% of their maximum amplitude by 20 min ("rundown"). Because each cell varied in the time at which the maximal current amplitude was recorded, Dyn A was applied when the currents had finished the runup phase and were just beginning to decrease, rather than at a set time after patch rupture. This was done to minimize variability in Dyn A-mediated inhibition of currents between diabetic and control animals that might be due simply to underlying current runup or rundown. After eliciting a current using the protocol described above (pre-Dyn A current), Dyn A prepared as described above was applied to the isolated cells using pressure ejection (compressed air; 0.5 psi) from a glass micropipette "puffer" with 10-40 m tip opening positioned ‫ف‬ 50 mm from the neuron being recorded. The drug pipette was lowered into the bath immediately before a 2 s application of drug. Currents were evoked by the depolarization protocol described above at 2 and 15 s after drug application (post-Dyn A currents). If the inhibitory response to Dyn A at 15 s was larger than the response at 2 s (suggesting that the full effect of that drug concentration was delayed or might be submaximal), a second application of the same drug concentration for 3 s was performed 30 s after the first application. Currents were elicited 2 s after the second application, after which the drug pipette was removed from the bath. Currents were elicited at 30-s intervals until recovery from the drug effect was maximal, then -CgTx (10 mM) was applied using a second micropipette puffer with the same protocol as described for the Dyn A application. In neurons in which currents could still be elicited after administration of -CgTx, 0.1 M capsaicin was applied via a third micropipette to assess capsaicin sensitivity, defined as a reduction of Ͼ 10% in current amplitude.
Analysis of calcium currents. Binary data files were analyzed with the program CLAMPAN. Leak currents assessed by hyperpolarizing commands of equal value to those used to depolarize the cell were digitally subtracted from I Ca . There was no significant difference in the leak currents measured in control (68 Ϯ 44 pA; n ϭ 24) and diabetic neurons (87 Ϯ 32 pA; n ϭ 20). To control for the possibility that alterations in I Ca between the control and diabetic groups occurred simply on the basis of variations in cell size, the current density (I DCa [pA pF Ϫ 1 ]) was determined. 10 small depolarizing calibration voltage pulses (V c ϭ ϩ 5 mV for 12 ms) performed immediately after patch rupture were averaged, and whole cell capacitance (proportional to surface area) was calculated using the following formula:
where C ϭ capacitance (pF), A (pF mV Ϫ 1 ) ϭ the area under the capacitance current curve from the peak inward current to the point at which I Ca ϭ 0, and V ϭ calibration voltage step (mV). Peak inward currents were divided by the cell capacitance, and the normalized current density (I DCa ) expressed in units of pA pF
. The percent inhibition caused by Dyn A application was calculated using the following formula:
where Pre-Dyn A I DCa was the current recorded immediately before lowering the drug micropipette into the bath, and Post-Dyn A I DCa was the lower of the two currents elicited at 2 and 15 s after Dyn A application. The difference between the resulting fraction and 1 was calculated and expressed as a percentage of 100.
Measurement of [Ca 2ϩ ] i . Using the Fura-2 technique (21), [Ca 2ϩ ] i was measured in DRGs prepared as described above. Coverslips were incubated for 2 h in MEM containing 1 M Fura-2 AM (acetoxymethyl ester and free acid; Molecular Probes, Eugene, OR) at 37ЊC in a light-tight water bath, then placed into a perfusion chamber on the stage of an inverted microscope (Nikon Inc., Melville, NY) and superfused continuously with oxygenated Krebs buffer at 37ЊC. On each coverslip, a single isolated, phase-bright DRG in the size range of interest (20-40 m) was selected using a micrometer in the ocular of the microscope. To avoid any bias due to decreased responsiveness to depolarization in neurons previously depolarized, only one neuron was studied on each coverslip. Fluorescence was elicited by illumination with light wavelengths alternating between 340 and 380 nm at 0.5 s intervals. Fluorescence was recorded using a SPEX fluorescence detection apparatus (SPEX DM 3000; SPEX Industries, Inc., Edison, NJ). The ratio of the signals generated at 340 and 380 nm was used to calculate [Ca 2ϩ ] i (nM) by the method of Grynkiewicz et al. (21) . Calibration of [Ca 2ϩ ] i was performed according to Gelperin et al. (22) . The background light intensity in the absence of cells (F 340,bk ; F 380,bk ) was subtracted from the cell signal and used to compute the 340:380 ratio (R) ϭ (F 340 Ϫ F 340,bk ):(F 380 Ϫ F 380,bk ). R min and R max were determined as described by Friel and Tsien (23 The effect of pertussis toxin was investigated by pretreatment of DRGs with Fura-2 loading medium containing PTX 250 ng ml Ϫ1 for 3-4 h before recording.
Statistical analysis. Peak calcium current densities obtained by analysis of individual recordings were analyzed using the statistical software package GraphPad Prism (GraphPad Software, Inc., San Diego, CA). Significance was determined using two-way ANOVA and the two-tailed Student's t test and defined as a P value Ͻ 0.05 (24) .
Results
Diabetes was associated with significant enhancement of highthreshold calcium current density (I DCa ) and decreased nerve conduction velocity. Diabetic animals demonstrated significant alterations in body weight, blood glucose, glycated hemoglobin, and significant slowing of nerve conduction velocity compared to nondiabetic control animals (Table I) . DRG neurons from animals diabetic for 7-10 mo or age-matched nondiabetic controls were prepared as described in Methods, and experiments were performed on neurons 20-40 m in diameter. After patch rupture, whole-cell, high-threshold calcium
currents were elicited at 30 s intervals by depolarizing from a holding potential of Ϫ80 mV to ϩ10 mV for 100 ms. Between depolarizations, the neurons were held at Ϫ80 mV. Calcium current density (I DCa ) was calculated by dividing the whole-cell current by the whole-cell capacitance calculated from calibration voltage steps performed immediately after patch rupture. As we have shown previously (9) , I DCa increased 20-30% in amplitude during the initial 2-5 min after patch rupture (runup), after which current density decreased at a relatively steady rate (rundown) such that by 20 min after patch rupture, the current amplitude was ‫ف‬ 60% of the maximum amplitude recorded. Current rundown occurred at a similar rate in diabetic and control neurons (9) . High-threshold I DCa in DRG neurons from diabetic animals was significantly enhanced compared to controls (Table II) .
Diabetes was associated with decreased Dyn A-mediated inhibition of high-threshold calcium current density (I DCa ). I DCa was elicited at 30-s intervals until the maximum current density was observed (usually between 2 to 5 min after patch rupture). When I DCa had reached maximum levels, a micropipette puffer containing Dyn A was lowered into the bath, and the tip placed within 50 M of the neuron being recorded. Dyn A was applied for 2 s using air pressure ejection. Currents were elicited immediately before lowering the micropipette (pre-Dyn A), 2 s and 15 s after application of Dyn A (post-Dyn A). In neurons that demonstrated additional inhibition at 15 s compared to 2 s, a second application of Dyn A was performed for 2 s, and currents were elicited 2 s later, then at 30 s intervals until partial or complete recovery of high-threshold I DCa from inhibition was observed (usually within 3-5 min). After drug application, the pipette was immediately removed from the recording bath. Fig. 1 shows the inhibitory effect of Dyn A application on I DCa recorded from diabetic and nondiabetic control DRGs. In Fig. 1 A, the effect of 1 M Dyn A on typical highthreshold calcium currents recorded in a control neuron and a neuron from a diabetic animal is shown. Currents recorded in control DRG neurons were inhibited by Dyn A at concentrations of 1, 3, and 5 M by 18Ϯ3% (n ϭ 6), 25Ϯ4% (n ϭ 5), and 37Ϯ7% (n ϭ 3), respectively (Fig. 1 B) . Compared to controls, DRG neurons from diabetic animals demonstrated significantly (P Ͻ 0.05) less inhibitory effect of Dyn A; 6Ϯ2% (n ϭ 6), 8Ϯ2% (n ϭ 4), and 11Ϯ3% (n ϭ 3) at 1, 3, and 5 M, respectively. The decreased inhibitory response in diabetic DRGs could not be overcome by increasing the concentration of Dyn A to levels as high as 5 M. After recovery from Dyn A-mediated inhibition, the irreversible N-type channel blocker -conotoxin GVIA (-CgTX; 10 M) was applied for 2 s using a second micropipette lowered into the recording bath. Omega-CgTX decreased control I DCa by 48Ϯ4% (n ϭ 11) and diabetic I DCa by 56Ϯ7% (n ϭ 10). In the presence of -CgTX, Dyn A-mediated inhibition was almost abolished in both control and diabetic neurons (Fig. 2) . Preincubation with PTX 250 ng ml Ϫ1 at 37ЊC for between 3 and 4 h before recording caused a modest, nonsignificant increase in the mean amplitude of peak I DCa elicited in both control (120.6Ϯ18.3 pA pF
Ϫ1
, n ϭ 7) and diabetic DRGs (175.6Ϯ28.6 pA pF
, n ϭ 8) (compared with Peak I DCa in Table II) , and markedly reduced the inhibitory effect of 3 M Dyn A on I DCa (percent inhibition post-PTX: control 10Ϯ2 (n ϭ 6); diabetic 5Ϯ1 (n ϭ 4); not significant).
Cytosolic calcium [Ca 2ϩ ] i studies. Isolated, dissociated DRGs in a size range similar to those used in electrophysiologic recording were selected and [Ca 2ϩ ] i was measured in individual isolated neurons using the Fura-2 method. The neuron diameter was measured using a scale in the microscope ocular. There was no significant difference in DRG diameter between neurons from diabetic animals (36.3Ϯ1.8; n ϭ 27) and those from age-matched nondiabetic controls (32.6Ϯ3.5; n ϭ 25). DRGs were perfused with oxygenated Krebs solution for 30 s while basal [Ca 2ϩ ] i was monitored, then depolarized by perfusion with 50 mM KCl-containing Krebs buffer for 6 s (Fig. 3 A) . Application of 50 mM KCl caused an increase in [Ca 2ϩ ] i that demonstrated an initial peak, followed by a plateau phase that recovered to basal levels over several minutes. After allowing [Ca 2ϩ ] i to recover to basal levels, the neuron was perfused with Ca 2ϩ -free Krebs buffer containing 1 mM EGTA for 1 min, then re-challenged with 50 mM KCl in Ca 2ϩ -free Krebs buffer.
The [Ca 2ϩ ] i response to 50 mM KCl in DRGs from control and diabetic animals was abolished by removal of external Ca 2ϩ , and restored by re-perfusion with Ca 2ϩ -containing buffer. The amplitude of the peak response decreased with repeated exposures to elevated KCl. Fig. 3 (Fig. 4) . When compared to the [Ca 2ϩ ] i response elicited by KCl-mediated depolarization of DRGs from control animals (755Ϯ56 nM), DRGs from diabetic animals demonstrated a significant increase in the peak [Ca 2ϩ ] i response (1033Ϯ70; P Ͻ 0.01) to a 6 s depolarization with 50 mM KCl. Capsaicin perfusion of DRGs from control and diabetic animals elicited an elevation in [Ca 2ϩ ] i that was similar in appearance to that stimulated by KCl (Fig. 5 A) . The mean peak [Ca 2ϩ ] i response to perfusion with 1 M capsaicin was significantly larger (P Ͻ 0.05) in DRGs from diabetic animals (835Ϯ68 nM) than in DRGs from age-matched controls (647Ϯ82 nM) (Fig. 4) .
Diabetes was associated with decreased Dyn A-mediated inhibition of the [Ca 2ϩ
] i response to depolarization. In the experiments testing Dyn A-mediated inhibition, 30 mM KCl, rather than 50 mM was used. ] i response to Dyn A. After a basal recording period, DRGs from either diabetic or control animals were depolarized by perfusion with 30 mM K ϩ -containing Krebs buffer for 6 s (Fig. 5 A) . ] i (Fig. 5 A) . Only neurons that demonstrated Ն 50% recovery in [Ca 2ϩ ] i amplitude after washout of Dyn A were analyzed, to ensure that the decreased response in the presence of Dyn A was not due simply to rundown of the response with time. Basal [Ca 2ϩ ] i was subtracted from the peak KCl-induced depolarization response before, and in the presence of, Dyn A to obtain a ⌬ peak [Ca 2ϩ ] i response. The ⌬ peak [Ca 2ϩ ] i responses to 1 and 3 mM Dyn A, and 3 M Dyn A after pretreatment with PTX are summarized in Fig. 5 B. Dyn A (1 M) reduced the peak [Ca 2ϩ ] i response to elevated KCl-evoked depolarization by 13Ϯ4% (n ϭ 4) in neurons from diabetic animals, which was significantly less than the reduction (27Ϯ5%; n ϭ 6) observed in age-matched control neurons (P Ͻ 0.05). Dyn A (3 M)-mediated inhibition of the ⌬ peak [Ca 2ϩ ] i response in DRGs from diabetic animals was also significantly less (33Ϯ8%; 710Ϯ62 nM; P Ͻ 0.01) than that observed in age-matched controls (73Ϯ6%; 247Ϯ78 nM) (Fig. 4  B) . Preincubation with PTX 250 ng ml Ϫ1 for 3-4 h before recording abolished the inhibitory [Ca 2ϩ ] i response to Dyn A in both diabetic (7Ϯ5%) and control (8Ϯ6%) DRGs.
Discussion
Our results suggest that diabetes mellitus is associated with decreased Dyn A-mediated inhibition of calcium influx via neuronal calcium channels. We believe that this is the first direct demonstration that opioid-mediated regulation of calcium channels is attenuated in neurons from diabetic animals. Both increased and decreased antinociceptive responses to opiate agonists have been described in diabetes mellitus (13) . The effect of diabetes on opiate-mediated inhibition of tail-flick and other avoidance responses may be related to the degree of hyperglycemia (25, 26) . Differential effects of opiates have been reported in the central and peripheral nervous system, with su- ] i response to KClmediated depolarization in calcium-containing and calcium-free medium for eight neurons.
persensitivity to opiate stimulation of ␦-1 receptors documented in the central nervous system (27) , while and opiate responses at the spinal level appear to be decreased in diabetes (13) , a finding which is consistent with our observation that Dyn A-mediated inhibition of calcium influx is decreased in spinal sensory ganglia.
Endogenous opiates, such as Dyn A, appear to play a physiologic role in modulation of calcium influx in DRGs, as Dyn A is present in neurons within the DRG and dorsal horn of the spinal cord (12) . In addition, and receptors are present on DRGs, as evidenced by mRNA production (28) and functional response to stimulation by selective and agonists and antagonists (17) . Decreased opiate receptor expression could explain the loss of opiate responsiveness in diabetes, and impaired vagal transport of opiate receptors has been demonstrated in streptozotocin-induced diabetic rats (14) . However, elevated beta endorphin binding sites on muscle have been documented in the type II obese diabetic mouse model (29) , and neuronal opiate receptor binding in the brain is not altered in spontaneously diabetic or streptozotocin-induced diabetic rats (30) . Alternatively, altered opiate receptor coupling to ion channels might be present in diabetes. To examine the possibility that opiate modulation of calcium channels was altered in diabetes, we used the opiate receptor agonist Dyn A. Dyn A inhibits high-threshold, voltage-activated calcium channels on DRGs via coupling to PTX-sensitive inhibitory (G o -type) G proteins (16) . Dyn A-mediated inhibition of voltage-activated calcium currents was significantly reduced in diabetes, suggesting that either opiate receptor number was reduced or that the signal transduction pathway coupling the receptor to the channel was altered. The inhibitory effect of Dyn A on DRG calcium currents involves both and receptors (16) , with activation of receptors predominating at doses at or less than 1 M, whereas doses above 1 M stimulate predominantly receptors (17) . In our studies, application of -CgTX abolished the differential inhibitory effect of Dyn A on currents recorded from diabetic DRGs compared to controls, however application of Dyn A still produced a small amount of inhibition (6-8%) in both control and diabetic DRGs. A small proportion (Ͻ 20%) of Dyn A-mediated inhibition of highthreshold calcium currents in DRG neurons has been shown to involve P and Q type calcium channels, in addition to N-type (31), therefore it is likely that the residual inhibition observed in our studies after application of -CgTX was due to an effect of Dyn A on P and Q channel currents. Our results imply that the inhibitory effect of Dyn A on these channels is not affected by diabetes. We studied neurons from DRGs in the size range 20-40 m, since our previous studies demonstrated that neu- ] i response to KCl-and capsaicin-mediated depolarization was enhanced in diabetes. Basal [Ca 2ϩ ] i measured before the first KCl-mediated depolarization was not significantly different in DRGs from diabetic and control animals. Application of 50 mM KCl-or 1 M capsaicin-containing Krebs buffer for 6 s caused an increase in peak [Ca 2ϩ ] i that was significantly (*P Ͻ 0.05, **P Ͻ 0.01) higher in DRG neurons from diabetic animals (n ϭ 9) than neurons from age-matched controls (n ϭ 9). Values are meanϮSEM. rons in this size range were predominantly (80%) capsaicin sensitive (9) . In addition to nociception, the capsaicin-sensitive population of small to medium sized DRG neurons likely subserve other sensory modalities such as stretch and chemosensation (32, 33) , therefore the enhancement in I DCa and [Ca 2ϩ ] i observed in this neuronal population implies alterations in these other sensory modalities in diabetes.
Activation of voltage-gated calcium channels in the cell outer membrane leads to a cascade of well-described intracellular events including: synaptic neurotransmitter release, secretion, release of calcium from intracellular pools, and activation of other ion channels. Recently, attention has focused on mechanisms by which calcium homeostasis is altered, as the resultant elevations in cytosolic calcium ([Ca 2ϩ ] i ) may contribute to neuronal cell injury and death (8, 10) . Our previous studies suggested that diabetes mellitus might alter intracellular pathways regulating calcium channels and lead to elevation in cytosolic calcium levels in response to depolarization. Therefore, one of the objectives of the present study was to examine whether the increased calcium currents observed in diabetes correlated with an increase in [ ] i observed in diabetes was likely associated with the enhanced calcium currents observed during depolarization (11) . In addition, neurons from diabetic animals also demonstrated an increase in [Ca 2ϩ ] i response to capsaicin, which acts via a ligand-gated pathway to cause calcium entry in neurons (34), indicating that both non-receptor-induced (KCl-mediated depolarization) and ligand-gated calcium entry are affected by diabetes in a parallel manner. The physiological concentration at which Dyn A acts on opiate receptors in spinal ganglia is unknown. At the same concentrations used in the electrophysiologic studies in this publication, and in previous studies (15, 35) , Dyn A caused a substantial reduction (Ͼ 70% with 3 M Dyn A) in KCl-mediated increased [Ca 2ϩ ] i in control neurons, which was significantly less in neurons from diabetic animals. At this dose, Dyn A acted via an opiate pathway, as the effects were blocked by naloxone (15) .
Because inhibitory G proteins modulate opiate-mediated inhibition of calcium influx, alterations in guanine nucleotidebinding (G) protein coupling to calcium channels may underlie the enhanced influx and cytosolic calcium present in diabetes. Decreased G protein levels and reduced functional activity of inhibitory G proteins have been described in non-neuronal tissues of a diabetic rat model (36) . In the present study, the effects of Dyn A on calcium current density and [Ca 2ϩ ] i response to depolarization in diabetic neurons were abolished by pertussis toxin, indicating that calcium channels remained coupled to inhibitory G proteins in diabetes. Finally, diabetes could affect other components of signal transduction pathways, such as protein kinase-mediated phosphorylation of various components of the receptor-effector system. Of interest, intracellular administration of cAMP-dependent protein kinase and protein kinase C (PKC) increase high-threshold calcium currents in DRG neurons (15, 37, 38) , and diabetes is associated with elevated levels of PKC isoforms (39). The role of phosphorylation remains to be elucidated, however, as decreased PKC levels have been correlated with impaired nerve conduction in diabetes (40) .
Alterations in intracellular calcium homeostasis resulting in increased [Ca 2ϩ ] i have been documented in several models of diabetes (8) . Abnormalities described include increased vascular responsiveness to agents such as Bay K 8644 that increase calcium influx (41) and decreased intracellular re-sequestration secondary to decreased Ca 2ϩ -Mg 2ϩ ATPase activity (42) . Increased total calcium content has been described in sciatic nerves from streptozotocin-induced diabetic rats (43) . The pathophysiologic significance and mechanism(s) underlying impaired calcium signaling are unclear. Increased cytosolic calcium has been demonstrated in various models of neuronal injury, and agents that decrease calcium influx have ameliorated loss of neuronal function in models of neuronal injury (10) . Preliminary reports of improvement in diabetic nerve conduction velocity with administration of the L-type calcium channel blocker nimodipine (44) suggest that the effect of increased calcium influx in diabetes may be injurious. However, modest elevation of [Ca 2ϩ ] i appears to be beneficial to neuronal growth, as exposure to moderately elevated KCl prevents neuronal loss due to programmed cell death or apoptosis (45) . We favor the interpretation that the observed enhancement in calcium influx in diabetes is pathophysiologic rather than compensatory because, in our previous studies (9) , the magnitude of enhancement in calcium influx increased with the duration of diabetes and paralleled the deterioration in nerve conduction velocity. Long-term administration of an aldose reductase inhibitor to diabetic animals was associated with normalization of nerve conduction velocity and neuronal calcium influx. In light of these findings, it would be interesting to determine whether aldose reductase treatment reversed the decreased effectiveness of opiate-mediated inhibition of calcium signaling in diabetes.
In summary, these results provide evidence of a cellular mechanism that may contribute to the decreased opiate sensitivity reported in sensory pathways in diabetes mellitus. Opiate-mediated inhibition of both voltage-activated calcium currents (I DCa ) and [Ca 2ϩ ] i response to depolarization was significantly decreased in sensory neurons from diabetic animals, compared to neurons from nondiabetic, age-matched controls. The congruent changes in calcium current density and elevated KCl/capsaicin-mediated increases in [Ca 2ϩ ] i suggest that an intracellular signal transduction mechanism common to both responses is impaired in diabetes. This abnormality may contribute to the mechanism(s) that underlie the pathophysiologic changes associated with diabetic neuropathy.
